P. Schnabel (Heidelberg, Germany), S. Janes (Harpenden, United Kingdom)
LSC 2011 Abstract: Molecular interplay between inflammation and occurrence of proliferation: Role of cadmium
S. Kundu (Kolkata, India)
|   |
LSC 2011 Abstract: Cigarette smoke-induced inflammation promotes melanoma cell metastasis in lung parenchyma
S. Bekaert, N. Rocks, M. Gueders, G. Paulissen, A. Noël, D. Cataldo (Liège, Belgium)
| |
SK-216, an inhibitor of plasminogen activator inhibitor-1, limits tumor growth and lung metastasis formation probably through the reduction of tumor angiogenesis
T. Masuda, N. Hattori, K. Hamai, S. Akita, T. Senoo, H. Iwamoto, S. Ohshimo, M. Kanehara, N. Ishikawa, K. Fujitaka, Y. Haruta, H. Murai, N. Kohno (Hiroshima, Japan)
| |
The long non-coding MALAT-1 RNA indicates a poor prognosis in NSCLC and induces migration and tumor growth
L. H. Schmidt, T. Spieker, S. Koschmieder, J. Humberg, A. Hascher, E. Bulk, A. Marr, L. Hilljean, W. Berdel, C. Müller-Tidow, R. Wiewrodt (Muemster, Ostercappeln, Germany)
| |
Expression of miR-126 and miR-126* in primary tumors and metastasis of adenocarcinoma and squamous carcinoma of the lung
L. Cavalho, S. Romano, M. Silva, P. Santos (Coimbra, Portugal)
| |
Expression and significance of VE-cadherin and E-cadherin in non-small cell lung cancer
H. Chen, J. Tao, M. Suzuki, Y. Li, Y. Wang (Chongqing, China; Kumamoto, Japan)
| |
Transcriptional regulation of the human osteopontin promoter in non-small cell lung cancer
M. K. Byun, J. A. Shin, H. J. Kim, Y. S. Chang (Seoul, Republic Of Korea)
| |
PD-L1 is a potential negative prognostic factor for non-small cell lung cancer: A 5-year-follow-up study
J. A. Huang, Y. B. Chen, C. Y. Mu (Suzhou, China)
| |
Expression of survivin and p53 protein in pulmonary tumours
E. Halasova, M. Adamkov, T. Matakova, E. Kavcova, E. Rozborilova, D. Dobrota (Martin, Slovakia)
| |
Inhibitor of DNA-binding (Id) – 1 and 3 proteins overexpression has impact on prognosis of lung adenocarcinoma
L. Antonangelo, T. Tuma, F. Vargas, E. Parra, R. Terra, M. Acencio, L. Teixeira, V. Capelozzi (São Paulo, Brazil)
| |
Adenovirus-mediated AP-2α down-regulates MnSOD expression in lung cancer A549 cells and its molecular mechanism
R. Zhou, Y. He, P. Chen, G. S. Zhang, S. H. Zou (Changsha, China)
| |
Telomerase (h-TERT) and targeting EGFR in non small cell lung carcinoma: A combined immunohistochemistry and chromogenic in situ hybridization study based on tissue microarrays
A. Stamatelopoulos, E. Tsiambas, P. Michos, I. Gakidis, A. Karameris, D. Bouros (Athens, Alexandropole, Greece)
| |
Inhibition of B7-H4 gene expression by RNA interference (RNAi) in lung cancer A549 cell line
S. Sun, Y. Lin, P. Huang, C. Jiang, Y. Jin (Nanjing, China)
| |
Novel functions of stanniocalcin-1 (STC1) through uncoupling protein 2 (UCP2) up-regulation; promoting survival of cancer cells under oxidative stress and inducing the uncoupling respiration (Warburg effect)
S. Ohkouchi, T. Kikuchi, M. Ebina, T. Nukiwa (Sendai, Japan)
| |
TNF neutralization ameliorates urethane-induced lung carcinogenesis
S. P. Karabela, G. T. Stathopoulos (Athens, Greece)
| |
Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected non-small cell lung cancer
S. Tanaka, N. Ishikawa, N. Hattori, H. Hamada, A. Yokoyama, N. Kohno (Hiroshima, Nankoku, Japan)
| |
Potential therapeutic significance of CIK cells in gefitinib resistant NSCLC with EGFR mutations
C. He, B. Yu, J. Wang, J. Xu (Guangzhou, Shenzhen, China)
| |
Expression of immunohistochemical markers chromogranin A, Ki-67, CD99, EGFR in resected pulmonary neuroendocrine tumors
Y. Slavova, D. Marinova, V. Maksimov, D. Petrov, E. Goranov, V. Djambazov (Sofia, Bulgaria)
| |